Hopp til hovedinnhold
Home
language-selector-globe Norway | no
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Norway
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Om oss 
      • Novartis i Norge 
      • Produkter 
      • Det globale styret i Novartis 
      • Forskning og utvikling 
      • Samarbeid 
      • Kliniske studier 
      • Pengeoverføring til helsetjenesten 
      Kvinnelig forsker på lab Om oss
    • Pasienter og pårørende 
      • Vårt løfte til pasienter og pårørende 
      • Utprøvende behandling - noe for deg? 
      • Behandlingsområder 
      • Bivirkningsrapportering 
      Venner med en kopp varm te på fjelltur Pasienter og pårørende
    • Nyheter 
      • Nyheter 
      • Pressefoto 
      • Pressekontakt 
      A photo of people in a meeting hall Nyheter
    • Bærekraft 
      • Vi jobber målrettet med bærekraft 
      • Etiske retningslinjer 
      • Arbeid med menneskerettighetene 
      Bærekraft Bærekraft
    • Helsepersonell 
      • Ressursside for helsepersonell 
      • Produkter 
      • Bivirkningsrapportering 
      • Klinske studier 
      • Forskning og utvikling 
      Helsepersonell Helsepersonell
    • Jobbe i Novartis 
      • Ledige stillinger 
      • Jobbe i Novartis 
      • Trivsel på jobben 
      Forretningskvinne ved trappen på kontoret Jobbe i Novartis
    • Kontakt oss 
    Mennesker i laboratorie Hjem
  1. Home
  2. Ledige stillinger
  3. Ledige stillinger
  • Sort by Sort ascending
  • Stillingstittel Sorter synkende
  • Sted
  • Land
  • Avdeling
  • Avdeling
  • Functional Area
  • Dato publisert
Stillingstittel Sorter synkende Sted Land Avdeling Avdeling Functional Area Dato publisert
Territory Business Executive Tamil Nadu India International Innovative Medicines Sales okt 01, 2024
Territory Business Executive Karnataka India International Innovative Medicines Sales okt 01, 2024
Territory Business Executive Tamil Nadu India International Innovative Medicines Sales okt 01, 2024
Territory Business Executive Kerala India International Innovative Medicines Sales okt 01, 2024
TERRITORY BUSINESS EXECUTIVE Delhi Territory India International Innovative Medicines Sales okt 01, 2024
Territory Business Executive Karnataka India International Innovative Medicines Sales okt 01, 2024
Territory Business Executive Jammu & Kashmir India International Innovative Medicines Sales okt 01, 2024
TERRITORY BUSINESS EXECUTIVE Rajasthan India International Innovative Medicines Sales okt 01, 2024
TERRITORY BUSINESS EXECUTIVE-1 Rajasthan India International Innovative Medicines Sales okt 01, 2024
Territory Sales Manager Cardio: Prague Prague Czech Republic International Innovative Medicines Sales okt 14, 2024
Territory Sales Manager Immunology: Moravia Prague Czech Republic International Innovative Medicines Sales okt 11, 2024
Therapeutic Area Biomarker Lead Cambridge (USA) USA Biomedical Research Pharma Research Research & Development mai 28, 2024
Therapeutic Area Biomarker Lead, Director Cambridge (USA) USA Biomedical Research Pharma Research Research & Development okt 21, 2024
Therapeutic Area Head Hematology (region LACan) East Hanover USA International Innovative Medicines Commercial & General Management okt 14, 2024
Therapeutic Area Head PKS (Global Health) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development sep 03, 2024
Therapeutic Data Strategy Director East Hanover USA Development Innovative Medicines Research & Development jul 02, 2024
Therapy Area Lead (ONCO/Hema & NS/Imm) Kyiv Ukraine International Innovative Medicines Commercial & General Management apr 16, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales okt 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales okt 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales okt 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales okt 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales okt 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales okt 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales okt 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales okt 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales okt 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales okt 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales okt 01, 2024
Third Party Risk Management Specialist Prague Czech Republic Operations CTS Procurement jul 30, 2024
Time Services Expert – US & Canada INSURGENTES Mexico People & Organization CTS Human Resources okt 22, 2024
TME Profiling Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Pharma Research Research & Development jul 07, 2024
Trainee Marketing (m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Marketing okt 18, 2024
Transformation Strategy Manager Jr Santo Amaro Brazil International Innovative Medicines Market Access okt 25, 2024
Treasury & Cash Management Team Lead Selangor Malaysia Finance CTS Audit & Finance aug 12, 2024
Treasury Cash Management Payment Specialist INSURGENTES Mexico Finance CTS Audit & Finance okt 16, 2024
Treasury Cash Management Specialist INSURGENTES Mexico Finance CTS Audit & Finance okt 25, 2024
Treasury Manager Moscow (City) Russian Fed. Finance CTS Audit & Finance jun 20, 2024
Trial Vendor Senior Manager Hyderabad (Office) India Development Innovative Medicines Research & Development sep 03, 2024
Trial Vendor Senior Manager Hyderabad (Office) India Development Innovative Medicines Research & Development sep 03, 2024
US Market Access Future Leaders Program East Hanover USA US Innovative Medicines Market Access okt 18, 2024
Utilities Maintenance & Reliability Engineer - Site Amiria Egypt Operations Innovative Medicines Technical Operations aug 19, 2024
UX/UI Designer Prague Czech Republic Operations CTS Technology Transformation okt 10, 2024
Validation Expert İstanbul Kurtköy Turkey Operations Innovative Medicines Technical Operations jul 22, 2024
Validation Expert İstanbul Kurtköy Turkey Operations Innovative Medicines Technical Operations sep 03, 2024
Validation lead İstanbul Kurtköy Turkey Operations Innovative Medicines Technical Operations jun 07, 2024
Validation Lead Schaftenau Austria Operations Innovative Medicines Technical Operations okt 03, 2024
Value Access Manager Bogota (Oncology) / Cali (Pharmaceuticals) Colombia International Innovative Medicines Market Access okt 10, 2024
Veeva CRM Architect Barcelona Gran Vía Spain Operations CTS Technology Transformation sep 03, 2024
Vendor Alliance Lead Associate Director (Remote) East Hanover USA Development Innovative Medicines Research & Development okt 17, 2024
Vendor Management & Governance Cambridge (USA) USA Biomedical Research Pharma Research Research & Development okt 04, 2024

Sider

  • ‹ Forrige side
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • › Neste side

Novartis Norge

Bli kjent med Novartis
  • Om oss
  • Kontakt oss
  • Jobbe i Novartis
  • Informasjon til pasienter og pårørende
Nyheter og medieressurser
  • Nyheter
  • Pressefoto
  • Pressekontakt
Våre behandlinger
  • Våre legemidler
  • Behandlingsområder
  • Forskning og utvikling
  • Informasjon til helsepersonell
Novartis' andre nettsider
  • Novartis Globalt
  • MedHub Norge
Bunntekst-bunn
© 2024 Novartis Norge
  • Personvern og GDPR
  • Brukervilkår for denne nettsiden
  • Informasjon om informasjonskapsler
  • Oversikt over denne nettsiden
  • Tilgjengelig
Novartis' andre nettsider
Denne nettsiden er beregnet på norske besøkende